XTL Biopharmaceuticals Sponsored ADR had a revenue of 162.00K in the quarter ending Sep 30, 2024, with Infinity%. This bring the company's revenue in the last twelve months to 162.00K, Decreased Infinity%. In the fiscal year ending Dec 31, 2024, XTL Biopharmaceuticals Sponsored ADR had annual revenue of 451.00K with Infinity% growth.